← Back to all trials
Not Yet Recruiting
NCT07637721
Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under Sedation
Conditions: Choledocholithiasis With Cholecystitis With Obstruction, Obstructive Jaundice, Pancreatitis, Cholelithiasis
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 410
Sponsor: Zhejiang University
Location: Tianjin Nankai Hospital, Tianjin Medical University Tianjin Tianjin Municipality
Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is commonly used for the diagnosis and treatment of pancreatobiliary diseases. While Monitored Anesthesia Care (MAC) enhances the efficiency of ERCP, deep sedation introduces significant airway risks, particularly hypoxemia resulting from sedative-induced upper airway collapse. With reported hypoxemia rates ranging from 10% to 69%, and the potential for severe complications such as myocardial ischemia and neurological damage, effective airway management is paramount. Supraglottic oxygenation via oral transtracheal catheter provides a viable method for relieving obstruction and enabling positive pressure ventilation, serving as a less invasive alternative to tracheal intubation. Despite its proven utility in other settings, this technique has not yet been evaluated in the context of deeply sedated ERCP.
Eligibility Criteria
Inclusion Criteria:
* Age≥18years
* The ASA classification ranges from I to III
* Patients have signed the informed consent form
* Patients scheduled to undergo sedated ERCP examination procedure
Exclusion Criteria:
* Severe cardiac dysfunction (\37.5°C);
* Confirmed pregnancy or current breastfeeding;
* Hypersensitivity to sedative drugs such as propofol;
* Current participation in other clinical trials;
Source: ClinicalTrials.gov (NCT07637721). StuddyBuddy aggregates publicly available trial information.